Analysts: Teva Pharmaceutical Industries Ltd (TEVA.N)

TEVA.N on New York Stock Exchange

57.18USD
26 Dec 2014
Price Change (% chg)

$0.09 (+0.16%)
Prev Close
$57.09
Open
$57.01
Day's High
$57.67
Day's Low
$57.00
Volume
194,252
Avg. Vol
692,133
52-wk High
$58.93
52-wk Low
$39.53

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 1.31 December 27 Dec 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 8 8 8 8
(2) OUTPERFORM 10 7 8 8
(3) HOLD 10 13 14 14
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.07 2.18 2.20 2.20

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 22 5,174.95 5,455.00 4,964.00 5,056.96
Quarter Ending Mar-15 11 4,867.22 5,100.40 4,620.00 --
Year Ending Dec-14 26 20,293.40 20,595.00 20,067.00 19,784.90
Year Ending Dec-15 26 19,454.00 20,361.10 18,101.60 19,744.40
Earnings (per share)
Quarter Ending Dec-14 24 1.31 1.38 1.22 1.11
Quarter Ending Mar-15 14 1.26 1.41 1.15 1.36
Year Ending Dec-14 27 5.07 5.14 4.95 4.66
Year Ending Dec-15 28 5.14 5.71 4.71 4.62
LT Growth Rate (%) 6 1.27 3.10 -0.90 -0.05

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 5,099.24 5,058.00 41.24 0.81
Quarter Ending Jun-14 5,095.32 5,045.00 50.32 0.99
Quarter Ending Mar-14 5,114.30 5,001.00 113.30 2.22
Quarter Ending Dec-13 5,188.66 5,430.00 241.34 4.65
Quarter Ending Sep-13 5,004.67 5,059.00 54.33 1.09
Earnings (per share)
Quarter Ending Sep-14 1.24 1.32 0.08 6.49
Quarter Ending Jun-14 1.22 1.23 0.01 0.61
Quarter Ending Mar-14 1.22 1.22 0.00 0.36
Quarter Ending Dec-13 1.40 1.42 0.02 1.14
Quarter Ending Sep-13 1.26 1.27 0.01 0.67

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 5,174.95 5,172.18 5,173.90 5,294.17 5,056.96
Quarter Ending Mar-15 4,867.22 4,886.13 4,958.50 4,981.39 --
Year Ending Dec-14 20,293.40 20,291.10 20,298.20 20,421.40 19,784.90
Year Ending Dec-15 19,454.00 19,489.70 20,074.00 20,287.30 19,744.40
Earnings (per share)
Quarter Ending Dec-14 1.31 1.30 1.31 1.27 1.11
Quarter Ending Mar-15 1.26 1.26 1.21 1.21 1.36
Year Ending Dec-14 5.07 5.07 5.07 4.95 4.66
Year Ending Dec-15 5.14 5.14 5.08 4.96 4.62

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 1 0 6 6
Quarter Ending Mar-15 0 1 0 5
Year Ending Dec-14 1 0 7 6
Year Ending Dec-15 0 1 0 17
Earnings
Quarter Ending Dec-14 1 0 5 5
Quarter Ending Mar-15 1 0 3 1
Year Ending Dec-14 1 0 5 4
Year Ending Dec-15 1 0 13 4

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: GlobalData
$125.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks